New

Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement
Advertisement

HTECvsGNOMETF Comparison

ETF 1
HTEC

Robo Global Healthcare Technology and Innovation ETF

This fund is part of
Multiple Trends
+0.41%
VS
ETF 2
GNOM

Global X Genomics & Biotechnology ETF - USD

This fund is part of
BioTech & Genomics
+0.53%

Robo Global Healthcare Technology and Innovation ETF (HTEC) belongs to the Multiple Trends segment. Global X Genomics & Biotechnology ETF - USD (GNOM) is part of the BioTech & Genomics segment. HTEC's top 3 sector exposures are Health Care, Consumer Discretionary and Information Technology. In contrast, GNOM's top sector exposures are Health Care,  HTEC is more expensive with a Total Expense Ratio (TER) of 0.8%, versus 0.5% for GNOM. HTEC is down -8.89% year-to-date (YTD) with +$2M in YTD flows. GNOM performs better with -0.61% YTD performance, and -$602K in YTD flows. Run a side-by-side ETF comparison of HTEC and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HTEC vs GNOM performance and flow charts

Performance

051015%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-1,000,000-500,0000500,0001,000,0001,500,000Mar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
HTEC
GNOM
+1.67%+9.18%
-12.13%-5.27%
-8.89%-0.61%
+20.39%+39.87%
+7.17%-7.16%
-30.01%-49.04%
Flows
HTEC
GNOM
+$2M-$829K
+$2M+$1M
+$2M-$602K
-$2M-$14M
-$47M-$106M
-$86M+$100K
Volatility and drawdown
3M1Y3Y5Y
Volatility
HTEC
GNOM
+22.13%+29.23%
+19.97%+27.41%
+20.14%+28.83%
+23.84%+33.25%
Max drawdown
HTEC
GNOM
-13.63%-13.73%
-16.84%-18.16%
-28.61%-46.50%
-56.05%-72.17%
Max drawdown duration
HTEC
GNOM
90d87d
97d98d
546d1081d
1700d1764d
Trading data

Create an account to view trading data

Join for free
HTEC
GNOM
Last sale
5/1/2026 at 3:56 PM
$33.48
$45.36
Previous close
04/29/2026
$33.41
$43.95
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of April 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
HTEC
GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 5/1/2026 at 3:56 PM
Live
Closed
HTEC
GNOM
Last price
$33.48
$45.36
1D performance
+0.22%
+3.22%
AuM$50.07 M$50.90 M
E/R0.8%0.5%
Characteristics
HTEC
GNOM
Management strategyPassivePassive
ProviderROBO Global ETFsGlobal X
BenchmarkROBO Global Healthcare Technology and InnovationSolactive Genomics Index
N° of holdings5545
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 25, 2019April 5, 2019
ESGYesNo
Advertisement
Exposure

Countries

HTEC
USA
71.15%
Other
28.85%
GNOM
USA
87.57%
Other
12.43%

Sectors

HTEC
Health Care
86.89%
Other
13.11%
GNOM
Health Care
88.49%
Other
11.51%
Advertisement

Diversification

HTEC

Total weight of top 15 holdings out of 15

30.9%
GNOM

Total weight of top 15 holdings out of 15

66.21%

Top 15 holdings

Data as of March 31, 2026
HTEC
AXOGEN
2.46%
ARROWHEAD PHARMACEUTICALS INC
2.22%
ALNYLAM PHARMACEUTICALS
2.19%
GUARDANT HEALTH INC
2.15%
NATERA
2.14%
THERMO FISHER SCIENTIFIC
2.07%
VERTEX PHARMACEUTICALS
2.07%
MEDPACE HOLDINGS INC
2.01%
INTUITIVE SURGICAL
1.99%
LIVANOVA
1.98%
REGENERON PHARMACEUTICALS
1.98%
ILLUMINA
1.93%
STRYKER
1.91%
IQVIA HOLDINGS INC
1.90%
UTD THERAPEUT
1.89%
GNOM
MODERNA INC
8.48%
ARROWHEAD PHARMACEUTICALS INC
6.21%
US74006W2070
6.13%
ILLUMINA
5.52%
GUARDANT HEALTH INC
5.18%
VERTEX PHARMACEUTICALS
4.61%
BIOMARIN PHARMACEUTICAL
4.59%
NATERA
4.21%
BIO-TECHNE CORP
3.64%
BIONTECH SE ADR
3.58%
CRISPR THERAPEUTICS
3.08%
BRISTOL-MYERS SQUIBB
3.05%
ALNYLAM PHARMACEUTICALS
2.85%
TWIST BIOSCIENCE CORP
2.54%
ASTRAZENECA
2.53%
Frequently asked questions about HTEC and GNOM

How have the HTEC and GNOM ETFs performed in 2026?

As of April 29, 2026, HTEC is down -8.89% year-to-date (YTD), while GNOM has lost -0.61%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: HTEC or GNOM?

Year-to-date, the HTEC ETF saw +$2M in flows, compared to -$602K for GNOM.

Which ETF is more volatile: HTEC or GNOM?

Over the past year, HTEC had a volatility of 19.97%, while GNOM experienced 27.41%.

Which ETF is bigger: HTEC or GNOM?

As of April 29, 2026, HTEC holds $50.07 M in assets under management (AUM), while GNOM manages $50.90 M.

What sectors do the HTEC and GNOM ETFs invest in?

HTEC leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the HTEC ETF and GNOM ETF?

HTEC top holdings include AXOGEN, ARROWHEAD PHARMACEUTICALS INC and ALNYLAM PHARMACEUTICALS. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

Which ETF is more diversified: HTEC or GNOM?

HTEC holds 56 securities with 30.9% of its assets in the top 15. GNOM has 47 securities and a top 15 weight of 66.21%.

Advertisement
Latest news about HTEC & GNOM
Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast